P
Precigen
Biologically-based products that improve the quality of life and the health of the planet
At a glance
- Status
- Listed
- Founded
- 1998
- Headquarters
- Germantown, United States
- Listing
- IPO 2013
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- NPNewVa Capital Partners
- TLThird Security LLC
Source: Dealroom Talent Intelligence.
Alumni founders
Former Precigen employees who went on to found companies, sorted by Dealroom signal score.
KBKrystal BiotechEst. 2016
Suma KrishnanUnited States
GLGlycomineEst. 2013
Agnes RafalkoUnited States
BLBlinkTBIEst. 2017
Ryan FioriniUnited States
BHBenson HillEst. 2012
Matt CrispUnited StatesGlobal footprint
team presence
across markets
Patents
100 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Precigen was the backer or acquirer, 2015–2017. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Precigen's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Precigen's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Precigen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Precigen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.